Download Gene Section AMP-19 (AML1 partner from chromosome 19) in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript 
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Gene Section
Short Communication
AMP-19 (AML1 partner from chromosome 19)
Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
(JLH)
Published in Atlas Database: February 2000
Online updated version : http://AtlasGeneticsOncology.org/Genes/AMP19ID235.html
DOI: 10.4267/2042/37581
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2000 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Identity
Implicated in
Location : 19q13.4
t(19;21)(q13.4;q22) with AML1
involvement
DNA/RNA
5.5 kB mRNA.
Disease
Acute non lymphocytic leukemia (ANLL) secondary to
toxic exposure.
Protein
References
Transcription
Hromas R, Busse T, Carroll A, Mack D, Shopnick R, Zhang
DE, Nakshatri H, Richkind K. Fusion AML1 transcript in a
radiation-associated leukemia results in a truncated inhibitory
AML1 protein. Blood. 2001 Apr 1;97(7):2168-70
Expression
Wide; highest expression in heart.
Homology
This article should be referenced as such:
None.
Atlas Genet Cytogenet Oncol Haematol. 2000; 4(1)
Huret JL. AMP-19 (AML1 partner from chromosome 19). Atlas
Genet Cytogenet Oncol Haematol. 2000; 4(1):10.
10
Related documents